Targeting of superoxide dismutase and catalase to vascular endothelium

Journal of Controlled Release

Volumn 71, Issue 1, 2001, Pages 1-21

  Muzykantov, Vladimir R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acute lung injury; Antioxidant enzymes; Drug delivery; Oxidative stress; Reactive oxygen species; Surface adhesion molecules

Indexed keywords

CATALASE; CD31 ANTIGEN; CHIMERIC PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; DIPEPTIDYL CARBOXYPEPTIDASE; HEPARIN BINDING PROTEIN; HYDROGEN PEROXIDE; INTERCELLULAR ADHESION MOLECULE 1; LIPOSOME; MACROGOL; MANGANESE SUPEROXIDE DISMUTASE; MEMBRANE ANTIGEN; PROTEIN ANTIBODY; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANTIGEN BINDING; ANTIOXIDANT ACTIVITY; BINDING AFFINITY; BLOOD VESSEL INJURY; CELL PROTECTION; CHEMICAL MODIFICATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG TARGETING; ENCAPSULATION; GENETIC MANIPULATION; GLYCOCALYX; HUMAN; INFLAMMATION; LUNG BLOOD VESSEL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIOXIDANTS; CATALASE; ENDOTHELIUM, VASCULAR; HUMANS; SUPEROXIDE DISMUTASE;

EID: 0035848422     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(01)00215-2     Document Type: Review

References (155)

1. Pulmonary strategies of antioxidant defense
2. Mechanisms of endothelial cell injury in acute inflammation
3. Exogenous oxidized LDL injures and alters the barrier function of endothelium in rats in vivo
4. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion
5. Measurement of endothelial cell free radical generation: Evidence for a central mechanism of free radical injury in postischemic tissues
6. +
7. Free radicals and tissue injury
8. Adhesion receptors of the immune system
9. Neutrophil adhesion to endothelial cells impairs the effects of catalase and glutathione in preventing endothelial injury
10. Adult respiratory distress syndrome: A radical perspective
11. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen
12. Nitric oxide, superoxide and peroxynitrite: The good, the bad and the ugly
13. Superoxide radical and superoxide dismutases
14. Extracellular superoxide dismutase in the vascular system of mammals
15. Potentiation of lung vascular response to endotoxin by superoxide dismutase
16. Superoxide dismutase: Rationale for use in reperfusion injury and inflammation
17. Superoxide dismutase and catalase as therapeutic agents for human diseases
18. Fate of superoxide dismutase in mice following oral route of administration
19. Pharmacokinetics of superoxide dismutase in rats after oral administration
20. Pharmacokinetics and safety of intravenous recombinant human superoxide dismutase in healthy subjects
21. 125I-labelled bovine superoxide dismutase (SOD) in the rat
22. Pharmacokinetics of recombinant human superoxide dismutase
23. Pharmacokinetics of extracellular-superoxide dismutase in the vascular system
24. Plasma clearance of human extracellular-superoxide dismutase C in rabbits
25. Heparin-released superoxide dismutase inhibits postischemic leukocyte adhesion to venular endothelium
26. Pharmacokinetics of recombinant human superoxide dismutase in healthy volunteers
27. Immunocytochemical study of binding and internalization of carrier-free Cu,Zn superoxide dismutase by cultured rat hepatocytes
28. In vivo uptake of Cu,Zn superoxide dismutase. Morphological evidence for preferential endocytosis and accumulation by sinusoidal liver cells
29. Immunotargeting of antioxidant enzymes to the pulmonary endothelium
30. Hepatocyte-specific distribution of catalase and its inhibitory effect on hepatic ischemia/reperfusion injury in mice
31. Targeted delivery and improved therapeutic potential of catalase by chemical modification: Combination with superoxide dismutase derivatives
32. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase
33. Anti-inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters
34. Effect of native and modified forms of superoxide dismutase and catalase on experimental silicosis in rats
35. Safety evaluation of free radical scavengers PEG-catalase and PEG-superoxide dismutase
36. Plasma clearance and immunologic properties of long-acting superoxide dismutase prepared using 35,000 to 120,000 dalton polyethylene glycol
37. Augmentation of antioxidant enzymes in vascular endothelium
38. Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: A phase II trial
39. Liposome-mediated augmentation of superoxide dismutase in endothelial cells prevents oxygen injury
40. Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis
41. Endocytosis-independent uptake of liposome-encapsulated superoxide dismutase prevents the killing of cultured hepatocytes by tert-butyl hydroperoxide
42. Effect of encapsulation in liposomes on the anti-inflammatory properties of superoxide dismutase after oral administration
43. Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen
44. 2 toxicity
45. Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats
46. Successful treatment of radiation-induced fibrosis using liposomal CuZn superoxide dismutase: Clinical trial
47. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain
48. Synthesis of a superoxide dismutase derivative that circulates bound to albumin and accumulates in tissues whose pH is decreased
49. Inhibition of oxygen toxicity by targeting superoxide dismutase to endothelial cell surface
50. Inhibition of ischemia and reflow-induced liver injury by a SOD derivative that circulates bound to albumin
51. Albumin-binding superoxide dismutase with a prolonged half-life reduces reperfusion brain injury
52. Lecithinized superoxide dismutase enhances its pharmacologic potency by increasing its cell membrane affinity
53. Effects of lecithinized superoxide dismutase on traumatic brain injury in rats
54. Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia
55. Plasma pharmacokinetics, nervous system biodistribution and biostability, and spinal cord permeability at the blood-brain barrier of putrescine-modified catalase in the adult rat
56. Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives
57. Conjugation of Cu,Zn-superoxide dismutase with succinylated gelatin: Pharmacological activity and cell-lubricating function
58. Role of reactive oxygen species in reperfusion injury of the rabbit lung
59. SOD and catalase in protection of cardiopulmonary bypass-induced cardiac dysfunction and cellular injury
60. Effects of recombinant human superoxide dismutase on increased lung vascular permeability and respiratory disorder in endotoxemic rats
61. Recombinant-human superoxide dismutase attenuates endotoxin-induced lung injury in awake sheep
62. Effects of recombinant human superoxide dismutase on tumor necrosis factor-induced lung injury in awake sheep
63. Suppression by superoxide dismutase of immune-complex-induced pulmonary alveolitis and dermal inflammation
64. Effects of manganese superoxide dismutase on lung fluid balance after smoke inhalation
65. Attenuation of hyperoxic lung injury in rabbits with superoxide dismutase: Effects on inflammatory mediators
66. Administration of bovine superoxide dismutase fails to prevent chronic pulmonary sequelae of neonatal oxygen exposure in the rat
67. Evaluation of reexpansion pulmonary edema following unilateral pneumothorax in rabbits and the effect of superoxide dismutase
68. Endotoxin-induced hydrogen peroxide production in intact pulmonary circulation of rat
69. Catalase prevents prostanoid release and lung lipid peroxidation after endotoxemia in sheep
70. Neutrophil-dependent, oxygen-radical mediated lung injury associated with acute pancreatitis
71. Reactive oxidants mediate TNF-induced leukocyte adhesion to rat mesenteric venular endothelium
72. The effect of allopurinol and catalase on cardiovascular hemodynamics during hemorrhagic shock
73. Safety and plasma concentrations of bovine superoxide dismutase administered to human premature infants
74. Catalase prevents increased lung vascular permeability during air emboli in unanesthetized sheep
75. Protective effects of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis
76. Pretreatment with catalase or dimethyl sulfoxide protects alloxan-induced acute lung edema in dogs
77. SOD inhibits radiation-induced lung injury in hamsters
78. Intravenous eugenol causes hemorrhagic lung edema in rats: Proposed oxidant mechanisms
79. Modulation of oxidant lung injury by using liposome-entrapped superoxide dismutase and catalase
80. Normolipedaemic activity of liposomal-encapsulated SOD in rats
81. Lecithinized superoxide dismutase attenuates phorbol myristate acetate-induced injury in isolated dog lung
82. Effect of lecithinized-superoxide dismutase on the interstitial pneumonia model induced by bleomycin in mice
83. Effect of lecithinized superoxide dismutase (PC-SOD) on experimental pulmonary metastasis in mice
84. Lecithinized superoxide dismutase induces vasodilation; evidence of direct contribution of superoxide anions to modulating vascular tone
85. Mitigation of pulmonary oxygen toxicity in premature lambs with intravenous antioxidants
86. Approaches to prevention of asbestors-induced lung disease using polyethylene glycol (PEG)-conjugated catalase
87. Effect of polyethylene glycol-superoxide dismutase and catalase on endotoxemia in pigs
88. Polyethylene glycol-attached antioxidant enzymes decrease pulmonary oxygen toxicity in rats
89. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart
90. Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: A demonstration of myocardial salvage
91. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury
92. SOD reduces permeability and edema induced by hypertension in rats
93. Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia-reperfusion
94. Chronic treatment with PEG-SOD partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits
95. Antioxidants and antioxidant enzymes protect against pulmonary oxygen toxicity in the rabbit
96. Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis
97. Polyethylene glycol-conjugated superoxide dismutase in unilateral lung injury due to re-expansion (re-oxygenation)
98. Effect of superoxide dismutase on a rabbit model of chronic allergic asthma
99. Polyethylene glycol-conjugated superoxide dismutase attenuates septic lung injury in guinea pigs
100. Apparent effect of catalase on airway edema in guinea pigs. Role of endotoxin contamination
101. Polyethylene glycol-conjugated superoxide dismutase fails to augment brain superoxide dismutase activity in piglets
102. Evidence against the 'early protection-delayed death' hypothesis of superoxide dismutase therapy in experimental myocardial infarction. Polyethylene glycol-superoxide plus catalase does not limit myocardial infarct size in dogs
103. Inhibition of cytotoxicity by intracellular superoxide dismutase supplementation
104. Internalization of human extracellular-superoxide dismutase by bovine aortic endothelial cells
105. Binding of human extracellular-superoxide dismutase C to cultured cell lines and to blood cells
106. Rational design and expression of a heparin-targeted human superoxide dismutase
107. Does superoxide underlie the pathogenesis of hypertension?
108. Direct targeting of immunoerythrocytes provides local protection of human endothelial cells from damage by hydrogen peroxide
109. Protection of cultured endothelial cells from hydrogen peroxide-induced injury by antibody-conjugated catalase
110. Targeting of radiolabeled monoclonal antibody against ACE to the pulmonary endothelium
111. Immunotargeting of drugs to the pulmonary vascular endothelium as a therapeutic strategy
112. Streptavidin facilitates internalization and pulmonary targeting of anti-endothelial antibody (PECAM-1): A strategy for intraendothelial drug delivery
113. Angiotensin-converting enzyme and the changes of our concept through the years
114. Endothelial cells internalize monoclonal antibody to angiotensin-converting enzyme
115. Radioimmunoimaging of lung vessels: An approach using Indium-111-labeled monoclonal antibody to ACE
116. Lung is a target organ for monoclonal antibody to ACE
117. Interaction of monoclonal antibody to angiotensin-converting enzyme (ACE) with antigen in vitro and in vivo: Antibody targeting to the lung induces ACE antigenic modulation
118. Angiotensin-I-converting enzyme (CD143) on endothelial cells in normal and in pathological conditions
119. Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress
120. Lipopolysaccharides decrease ACE activity expressed by cultured human endothelial cells
121. Systemic administration of PAF in rat reduces specific pulmonary uptake of circulating monoclonal antibody to ACE
122. A phase I/II open label study of the safety and efficacy of an anti-ICAM-1 monoclonal antibody in early rheumatoid arthritis
123. Platelet-endothelial cell adhesion molecule-1 (PECAM-1) is involved in neutrophil recruitment in vivo
124. Apical topography and modulation of ICAM-1 expression on activated endothelium
125. Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide
126. Heterogeneity of expression of E- and P-selectins in vivo
127. Compartmentalized roles for leukocytic adhesion molecules in lung inflammation injury
128. Regional differences in constitutive and induced ICAM-1 expression in vivo
129. The biology of PECAM-1
130. Immunotargeting of glucose oxidase to endothelial cells induces intracellular generation of hydrogen peroxide and oxidative stress
131. Vascular immunotargeting: Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo
132. Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs
133. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody
134. PECAM-directed immunotargeting of active reporter enzyme to the heart
135. Imaging vascular endothelial activation: An approach using radiolabeled monoclonal antibodies against the endothelial adhesion molecule E-selectin
136. Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase DNA
137. Redox-mediated gene therapies for environmental injury: Approaches and concepts
138. Gene therapy for oxidant injury-treated diseases: Adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury
139. Cationic liposomes enhance targeted delivery and expression of exogenous DNA mediated by N-terminal modified poly(l-lysine)-antibody conjugate in mouse lung endothelial cells
140. Superoxide dismutase and catalase conjugated to polyethylene glycol increases enzyme activity and oxidant resistance
141. Improvement of therapeutic effect of human recombinant superoxide dismutase on ischemic acute renal failure in the rat via cationization and conjugation with polyethylene glycol
142. Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes
143. Manipulation of renal disposition of human recombinant superoxide dismutase by chemical modification
144. Effect of intravenous catalase on the pulmonary vascular response to endotoxemia in goats
145. Recombinant human superoxide dismutase reduces lung injury caused by inhaled nitric oxide and hyperoxia
146. 2 toxicity in the newborn rat
147. Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase
148. Polyethylene glycol-conjugated superoxide dismutase protects rats against oxygen toxicity
149. The effect of superoxide dismutase on the pathogenesis of radiation-induced pulmonary damage in the rat
150. Protective effect of liposome-entrapped superoxide dismutase and catalase on bleomycin-induced lung injury in rats. II. Phospholipids of the lung surfactant
151. Catalase pretreatment attenuates oleic acid-induced edema in isolated rabbit lung
152. Superoxide dismutase with heparin prevents increased lung vascular permeability during air emboli in sheep
153. SOD prevents the thrombin-induced increase in lung vascular permeability: Role of superoxide in mediating the alterations in lung fluid balance
154. Reduction of reperfusion injury by recombinant human superoxide dismutase administered intravenously just prior to reperfusion
155. Effect of CuZnSOD on endothelium-dependent vasodilation in patients with essential hypertension